Abstract
Coronavirus disease 2019 (COVID-19) is a new evolving infectious disease characterized as atypical pneumonia caused by severe acute respiratory syndrome-coronavirus-2(SARS-CoV-2). It was first seen in Wuhan, China, and later spread across the globe led to a worldwide pandemic affecting millions of people. The usual manifestations of COVID-19 include cough, sore throat, fever, dyspnoea, and fatigue with exposure recently. Most of COVID-19 patients may have mild or moderate disease, whereas severe to life-threatening disease course is seen in 5–10% of the patients. Several clinical trials are presently trying to find the most effective drug or combination of the drugs for this disease. This article aims to discuss the treatment strategies in different forms of medicine that are being used for COVID-19 patients and review the literature available.
| Original language | English |
|---|---|
| Pages (from-to) | 935-940 |
| Number of pages | 6 |
| Journal | Research Journal of Pharmacy and Technology |
| Volume | 15 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 26-02-2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'An Overview on Treatment Strategies by Allopathic and Alternative Forms of Medicines in Management of COVID-19'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver